Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1900 1
1904 1
1905 1
1906 1
1947 1
1948 3
1950 1
1951 1
1953 2
1954 2
1955 3
1956 1
1957 1
1958 7
1959 2
1960 2
1961 2
1962 2
1963 3
1964 3
1965 2
1966 5
1967 3
1968 5
1969 5
1970 7
1971 16
1972 19
1973 24
1974 16
1975 19
1976 27
1977 31
1978 23
1979 21
1980 19
1981 17
1982 31
1983 24
1984 33
1985 37
1986 35
1987 31
1988 38
1989 34
1990 36
1991 49
1992 39
1993 37
1994 34
1995 34
1996 44
1997 36
1998 30
1999 34
2000 32
2001 31
2002 32
2003 33
2004 43
2005 29
2006 29
2007 32
2008 28
2009 31
2010 27
2011 24
2012 34
2013 27
2014 31
2015 37
2016 29
2017 23
2018 26
2019 37
2020 35
2021 49
2022 41
2023 47
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

1,649 results

Results by year

Filters applied: . Clear all
Page 1
The Immunopathophysiology of Endometriosis.
Symons LK, Miller JE, Kay VR, Marks RM, Liblik K, Koti M, Tayade C. Symons LK, et al. Among authors: marks rm. Trends Mol Med. 2018 Sep;24(9):748-762. doi: 10.1016/j.molmed.2018.07.004. Epub 2018 Jul 24. Trends Mol Med. 2018. PMID: 30054239 Review.
Methodology for clinical research.
Kiani AK, Naureen Z, Pheby D, Henehan G, Brown R, Sieving P, Sykora P, Marks R, Falsini B, Capodicasa N, Miertus S, Lorusso L, Dondossola D, Tartaglia GM, Ergoren MC, Dundar M, Michelini S, Malacarne D, Bonetti G, Donato K, Medori MC, Beccari T, Samaja M, Connelly ST, Martin D, Morresi A, Bacu A, Herbst KL, Kapustin M, Stuppia L, Lumer L, Farronato G, Bertelli M; INTERNATIONAL BIOETHICS STUDY GROUP. Kiani AK, et al. Among authors: marks r. J Prev Med Hyg. 2022 Oct 17;63(2 Suppl 3):E267-E278. doi: 10.15167/2421-4248/jpmh2022.63.2S3.2769. eCollection 2022 Jun. J Prev Med Hyg. 2022. PMID: 36479476 Free PMC article. Review.
Ethical considerations regarding animal experimentation.
Kiani AK, Pheby D, Henehan G, Brown R, Sieving P, Sykora P, Marks R, Falsini B, Capodicasa N, Miertus S, Lorusso L, Dondossola D, Tartaglia GM, Ergoren MC, Dundar M, Michelini S, Malacarne D, Bonetti G, Dautaj A, Donato K, Medori MC, Beccari T, Samaja M, Connelly ST, Martin D, Morresi A, Bacu A, Herbst KL, Kapustin M, Stuppia L, Lumer L, Farronato G, Bertelli M; INTERNATIONAL BIOETHICS STUDY GROUP. Kiani AK, et al. Among authors: marks r. J Prev Med Hyg. 2022 Oct 17;63(2 Suppl 3):E255-E266. doi: 10.15167/2421-4248/jpmh2022.63.2S3.2768. eCollection 2022 Jun. J Prev Med Hyg. 2022. PMID: 36479489 Free PMC article. Review.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance. Poeschel V, et al. Among authors: marks r. Lancet. 2019 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9. Lancet. 2019. PMID: 31868632 Clinical Trial.
Human Cloning: Biology, Ethics, and Social Implications.
Bonetti G, Donato K, Medori MC, Dhuli K, Henehan G, Brown R, Sieving P, Sykora P, Marks R, Falsini B, Capodicasa N, Miertus S, Lorusso L, Dondossola D, Tartaglia GM, Cerkez Ergoren M, Dundar M, Michelini S, Malacarne D, Beccari T, Connelly ST, Martin D, Bacu A, Herbst KL, Kapustin M, Stuppia L, Lumer L, Farronato G, Bertelli M. Bonetti G, et al. Among authors: marks r. Clin Ter. 2023 Nov-Dec;174(Suppl 2(6)):230-235. doi: 10.7417/CT.2023.2492. Clin Ter. 2023. PMID: 37994769 Free article. Review.
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Du… See abstract for full author list ➔ Vos T, et al. Among authors: marks r. Lancet. 2012 Dec 15;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2. Lancet. 2012. PMID: 23245607 Free PMC article.
Forefoot Success.
Granberry W, Schafer KA, McCormick JJ, Marks RM. Granberry W, et al. Among authors: marks rm. Instr Course Lect. 2021;70:587-610. Instr Course Lect. 2021. PMID: 33438938 Review.
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study.
Nowakowski GS, Yoon DH, Peters A, Mondello P, Joffe E, Fleury I, Greil R, Ku M, Marks R, Kim K, Zinzani PL, Trotman J, Huang D, Waltl EE, Winderlich M, Kurukulasuriya NC, Ambarkhane S, Hess G, Salles G. Nowakowski GS, et al. Among authors: marks r. Clin Cancer Res. 2022 Sep 15;28(18):4003-4017. doi: 10.1158/1078-0432.CCR-21-3648. Clin Cancer Res. 2022. PMID: 35674661 Free PMC article.
1,649 results